Product: Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5720-56
Reason for recall: Failed Impurities/Degradation Specifications:  out of specification test results for related compounds largest unknown impurity.
Recall initiated: 20170629
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated